Adults: All diseases of the respiratory tract connected to mucous secretion.
Adjunctive mucolytic therapy in patients with abnormal or viscid mucous secretions in such conditions as: Chronic bronchopulmonary diseases e.g., chronic emphysema, chronic asthmatic bronchitis, tuberculosis, bronchiectasis, primary amyloidosis of the lung; Acute bronchopulmonary disease e.g., pneumonia, bronchitis, tracheobronchitis.
Children aged 6 years and older: Reduction of sputum viscosity.